Pegasus Partners Ltd. increased its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 7.4% during the second quarter, Holdings Channel reports. The firm owned 12,696 shares of the healthcare conglomerate’s stock after buying an additional 876 shares during the period. Pegasus Partners Ltd.’s holdings in UnitedHealth Group were worth $1,793,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. MCF Advisors LLC boosted its position in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares during the period. Parkside Financial Bank & Trust boosted its position in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 238 shares during the period. Feltz Wealth PLAN Inc. bought a new position in UnitedHealth Group during the second quarter valued at about $143,000. Benjamin F. Edwards & Company Inc. boosted its position in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock valued at $153,000 after buying an additional 518 shares during the period. Finally, Evanson Asset Management LLC bought a new position in UnitedHealth Group during the second quarter valued at about $201,000. Institutional investors and hedge funds own 85.94% of the company’s stock.

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.37% on Monday, reaching $137.96. 2,035,489 shares of the company were exchanged. The firm has a market capitalization of $131.39 billion, a PE ratio of 21.59 and a beta of 0.57. The stock has a 50 day moving average of $139.85 and a 200 day moving average of $134.55. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. Equities analysts anticipate that UnitedHealth Group Inc. will post $7.92 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Friday, September 9th will be issued a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend is Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 39.12%.

Several research analysts have recently issued reports on UNH shares. Mizuho increased their price objective on shares of UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a report on Tuesday, July 19th. Credit Suisse Group AG restated a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 29th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Citigroup Inc. raised their target price on shares of UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 target price for the company in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $154.96.

In related news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.